Served in executive management leadership in various large and emerging healthcare companies, including those in pharmaceuticals, biotechnology, clinical diagnostics, medical technology, manufacturing, and research products

Formed The Channel Group, a strategic advisory business focused on transactional activities in healthcare sectors

Founder and CEO of Intergen Company

Formed Intergen through a management buyout of a division of Armour Pharmaceutical Company and led the company through a series of mergers and acquisitions globally as it became a leading GMP manufacturer of biologics to the biopharmaceutical and clinical diagnostic industries and a developer of research reagents and assays

Founder of BIO, the Biotechnology Innovation Organization, where he served as a member of the executive committee and Chair of the Emerging Companies Section. He was an active member of BIO's leadership during the period when the industry was in development

Participated in negotiations on FDA reform, health care reform, and appeared at the House Ways and Means committee several times

Served on public, private, and not for profit boards of directors, including service as Executive Chairman of a medtech company and a member of the executive committee of a public imaging company.

Served as a trustee of the New York Medical College